NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026

A Tender Notice
by NHS ENGLAND

Source
Find a Tender
Type
Framework (Goods)
Duration
2 year
Value
£878M
Sector
HEALTH
Published
17 Mar 2026
Delivery
01 Sep 2026 to 31 Aug 2028
Deadline
17 Apr 2026 12:00

Related Terms

Location

North East England:

Geochart for 1 buyers and 0 suppliers

1 buyer

Description

NHS Branded Framework Agreement – Lot 1 - Tranche A for the North of England and Midlands & East. Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion for a further 24 months. Lot 2 - Natalizumab for London and South of England. The period of Framework Agreement: 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.

Lot Division

1 CM/PHR/25/5730/01 - Tranche B for NOFE and MAE
  • Duration: 2 year
  • Value: £846M

Lot 1 - Tranche A for the North of England and Midlands & East.
2 CM/PHR/25/5730/02 - Natalizumab for London & SOFE
  • Duration: 1 year
  • Value: £32M

Lot 2 - Natalizumab for London and South of England. The period of Framework Agreement : 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.

Award Criteria

Price is not the only award criterion Price is not the only award criterion and all criteria are stated only in the procurement documents

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Options are available.
  • Renewals are available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

  • ocds-h6vhtk-051c98
  • FTS 023990-2026

Domains